Bausch Health Co. Inc. (BHC) Reports In-Line Q2 Revenue, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Bausch Health Companies Inc. Announces Second-Quarter 2021 Results
August 3, 2021 6:59 AM EDTLAVAL, Quebec, Aug. 3, 2021 /PRNewswire/ --
Second-Quarter 2021 Financial Results Revenues of $2.100 Billion GAAP Net Loss of $595 Million Adjusted EBITDA (non-GAAP)1Â of $826 Million GAAP Cash Generated from Operations of $395 Million Thomas J. Appio Appointed CEO of Bausch Pharma2Â Bausch Health Announced Plans to Pursue an Initial Public Offering for Solta Medical3 Revised 2021 Full-Year Revenue and Adjusted EBITDA (non-GAAP) Guidance Ranges, Primarily to Reflect Amoun Pharmaceutical DivestitureBausch Health Companies Inc.... More
